Philipp von Breitenbuch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Philipp von Breitenbuch has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Hans J. Schlitt
Department of Surgery, University of Regensburg Medical Center, Regensburg, Germany
1 shared publication- Hans Juergen Schlitt
Department of Surgery, University Hospital Regensburg, Regensburg, Germany
1 shared publication Pompiliu Piso
Department of Surgery, Krankenhaus der Barmherzigen Brüder, Regensburg, Germany
1 shared publication- Pompiliu Piso
Krankenhaus Barmherzige Brueder Regensburg
1 shared publication Thomas Boerner
Department of Surgery, University of Regensburg Medical Center, Regensburg, Germany
1 shared publicationTonia Jeiter
Department of Surgery, Krankenhaus der Barmherzigen Brüder, Regensburg, Germany
1 shared publication
Latest Publications
- 27 September 2018
- Published by Wiley in Journal of Surgical Oncology
- Vol. 118 (3) , 551-556
Safety of rectum anastomosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Background and Objectives: In highly selected patients with peritoneal carcinomatosis, cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can be an aggressive but worthwhile treatment regimen. Resection of the rectosigmoid is frequently performed with CRS. The aim of the study was to assess the safety of the rectal anastomosis in this setting.Methods: Between 2005 and 2016, 436 patients underwent CRS/HIPEC. Clinical data were analyzed with respect to the morbidity associated with a rectum resection.Results: In 436 patients, 174 rectum resections (40%) were performed with CRS, including 149 anterior resections of the rectosigmoid, 23 low anterior rectum resections, and 2 abdominoperineal rectum excisions. A total of 141 rectum anastomoses were performed; 33 patients received a permanent ostomy, and 48 patients received a protective ileostomy. After changing the operation technique of the rectum anastomosis, the number of protective ileostomies decreased from 65% to 20%. The overall postoperative morbidity was 31%. Rectal anastomotic leakages were seen in only 5% of cases.Conclusions: Anastomotic leakages of the rectum are rarely seen after CRS/HIPEC. HIPEC performed immediately after surgery seems to have no negative effect on the rectum anastomosis. Performing rectum anastomoses after CRS/ HIPEC appears to be a safe procedure.
- 27 September 2018
- Published by Wiley in Journal of Surgical Oncology
- Vol. 118 (3) , 551-556
Safety of rectum anastomosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Background and Objectives: In highly selected patients with peritoneal carcinomatosis, cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can be an aggressive but worthwhile treatment regimen. Resection of the rectosigmoid is frequently performed with CRS. The aim of the study was to assess the safety of the rectal anastomosis in this setting.Methods: Between 2005 and 2016, 436 patients underwent CRS/HIPEC. Clinical data were analyzed with respect to the morbidity associated with a rectum resection.Results: In 436 patients, 174 rectum resections (40%) were performed with CRS, including 149 anterior resections of the rectosigmoid, 23 low anterior rectum resections, and 2 abdominoperineal rectum excisions. A total of 141 rectum anastomoses were performed; 33 patients received a permanent ostomy, and 48 patients received a protective ileostomy. After changing the operation technique of the rectum anastomosis, the number of protective ileostomies decreased from 65% to 20%. The overall postoperative morbidity was 31%. Rectal anastomotic leakages were seen in only 5% of cases.Conclusions: Anastomotic leakages of the rectum are rarely seen after CRS/HIPEC. HIPEC performed immediately after surgery seems to have no negative effect on the rectum anastomosis. Performing rectum anastomoses after CRS/ HIPEC appears to be a safe procedure.
- 7 December 2017
- Published by Springer Nature in Surgical Endoscopy
- Vol. 32 (5) , 2288-2294
Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies
Complete macroscopic cytoreduction in patients with peritoneal carcinomatosis (PC) is the basic requirement for long-term survival. Diagnostic laparoscopy (DL) can be difficult and of limited clinical value secondary to postoperative or tumor-induced adhesions. The aim of this study was to evaluate the role of DL in patients with prior surgery and PC.
- 7 December 2017
- Published by Springer Nature in Surgical Endoscopy
- Vol. 32 (5) , 2288-2294
Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies
Complete macroscopic cytoreduction in patients with peritoneal carcinomatosis (PC) is the basic requirement for long-term survival. Diagnostic laparoscopy (DL) can be difficult and of limited clinical value secondary to postoperative or tumor-induced adhesions. The aim of this study was to evaluate the role of DL in patients with prior surgery and PC.